Clinical trials
Other Cancer clinical trials
Below are recruiting other cancer clinical trials, each written for real people, not researchers. We’re tracking 12,892 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05805319Recruiting
Food intervention for people with lung cancer on immunotherapy
This trial studies whether a specific diet can help people with non-small cell lung cancer who are receiving immunotherapy (a standard cancer treatment). It mainly checks whether participants can follow the diet plan and tolerate the food changes safely.
Montreal, QuebecAges 18 years+ - NCT07890402Recruiting
Cervical cancer screening support for immigrant women
This study helps Hispanic and East African immigrant women get cervical cancer screening. It aims to make screening easier and more accessible.
Rochester, MinnesotaAges 30–65 - NCT04682158RecruitingPhase 2
Propranolol plus standard treatment for esophageal cancer
This trial tests whether adding a drug called propranolol (a beta-blocker, commonly used for blood pressure) to your standard chemotherapy or chemoradiation can help treat esophageal cancer. Propranolol may block stress hormones that help cancer grow. The trial is for people who are about to start treatment for esophageal adenocarcinoma.
Buffalo, New YorkAges 18 years+ - NCT07890415RecruitingPhase 3
AI tool for melanoma diagnosis during skin checks
This study tests an artificial intelligence (AI) tool that helps doctors spot melanoma and other skin conditions during your regular skin check. The tool is meant to help with diagnosis for people with moles, new growths, or a history of skin cancer.
Stanford, CaliforniaAges 18 years+ - NCT04824027Recruiting
Breast elasticity imaging during chemotherapy for invasive cancer
This study uses a special ultrasound technique to measure how stiff (elastic) your breast tumor is during chemotherapy treatment before surgery. The goal is to see if changes in tumor stiffness can predict how well the treatment works. If you are already planned to receive chemotherapy before surgery, this study is likely a good fit.
New York, New YorkAges 18 years+ - NCT07888959Recruiting
Boxing and photography to improve body image and self-esteem
This study explores whether adapted boxing and photography can help people with blood cancers feel better about their bodies and themselves during treatment. If you are already doing adapted physical activity as part of your care, you may be able to join.
StrasbourgAges 18 years+ - NCT07888244Recruiting
Financial help for bone tumor surgery patients
This study tests a program that helps patients manage medical costs after being diagnosed with a primary bone tumor and planning surgery. It aims to reduce financial stress and improve overall well-being.
Shanghai, Shanghai MunicipalityAges Any age - NCT07890311Enrolling by invitationPhase 2
Study of vedotin for advanced bile duct cancer after first treatment
This trial tests a new drug called vedotin for people with advanced bile duct or gallbladder cancer that has grown after at least one prior treatment. The drug is given as an infusion and works by targeting cancer cells with a specific marker, potentially slowing or shrinking the tumor.
Jiangmen, GuangdongAges 18–80 - NCT06577441RecruitingPhase 2
Adding enasidenib to usual care for higher-risk MDS with IDH2 mutation
This trial tests whether adding enasidenib (a targeted pill) to the standard chemotherapy (cedazuridine-decitabine) works better than the chemotherapy alone for people with higher-risk myelodysplastic syndrome (MDS) whose cells have a specific change in the IDH2 gene.
Berkeley, CaliforniaAges 18 years+ - NCT07437963RecruitingPhase 1/Phase 2
Iberdomide plus chemoimmunotherapy for neuroblastoma that returned or did not respond
This trial tests adding a new drug called iberdomide to an existing chemoimmunotherapy regimen for children and young adults with neuroblastoma that has come back or not responded to treatment. The goal is to see if the combination is safe and more effective than current treatments.
Oakland, CaliforniaAges 1–30 - NCT06281080Recruiting
New robotic tool for removing early bladder tumors
This trial tests a new robotic system to remove bladder tumors in one piece (en-bloc resection) for people with early-stage, non-muscle invasive bladder cancer. It may offer a more precise surgical option for eligible patients.
ShatinAges 18–75 - NCT05484973Recruiting
Portable scalp cooling to help prevent chemotherapy hair loss
This study tests whether a portable cooling cap system can reduce hair loss for women with breast cancer who are planning certain chemotherapy treatments. It may help you keep more of your hair while you receive chemotherapy.
Tucson, ArizonaAges 21 years+ - NCT06246357RecruitingPhase 2
Testing adrenal gland function with a special scan
This trial uses a special PET scan (68Ga-PentixaFor) to check how well your adrenal glands are working if you have high aldosterone or cortisol levels. It helps doctors see if the glands are making too much hormone, which may guide treatment.
Bethesda, MarylandAges 18–120 - NCT07714538Recruiting
Breath test for detecting gastrointestinal cancers
This study tests whether a simple breath test can help detect different types of gastrointestinal cancers earlier. If you have been recently diagnosed with one of these cancers or have concerning abdominal symptoms but clear test results, your breath may help teach us how to spot these cancers sooner.
Maidstone, KentAges 18 years+ - NCT07657104Recruiting
HPV screening for women in the emergency department
This study offers free HPV testing to women who visit the emergency department and haven't been screened recently. It aims to catch early signs of cervical cancer so they can get treated sooner.
New Brunswick, New JerseyAges 30–65 - NCT04933435Recruiting
Image-guided radiation plus liver procedures for non-surgical liver cancer
This trial studies a combination approach—special, image-guided radiation and liver procedures—for liver cancer patients who cannot have surgery. It may help shrink tumors while protecting liver function by using planned, targeted treatment.
Durham, North CarolinaAges 18 years+ - NCT07673887RecruitingPhase 3
Study of a new drug combo for advanced stomach cancer
This trial tests a new drug called ASP2138 combined with chemotherapy and pembrolizumab for people with advanced stomach or gastroesophageal junction cancer that cannot be removed by surgery or has spread. It may help if your tumor has certain markers (CLDN18.2 and PD-L1) and you haven't had prior chemotherapy for advanced disease.
Saint Louis Park, MinnesotaAges 18 years+ - NCT07012044RecruitingPhase 1
Cedazuridine and decitabine after stem cell transplant for childhood leukemia
This trial tests if adding two chemotherapy drugs (cedazuridine and decitabine) along with a growth factor (filgrastim) can help prevent leukemia from coming back after a stem cell transplant. It is for children and young adults with high-risk acute myeloid leukemia who are in remission after transplant.
Birmingham, AlabamaAges Up to 21 years - NCT06157463Recruiting
FAPI imaging for newly diagnosed rectal cancer
This trial tests a new imaging agent called 68Ga-FAPI to see how well it finds rectal cancer and guides treatment. It's for people with new stage II or III rectal cancer who are about to start neoadjuvant therapy (treatment before surgery).
TaoyuanAges 18 years+ - NCT07616856Recruiting
Evaluating LumiSystem for cancer surgery margins
This study tests a device called LumiSystem that helps doctors check if all cancer cells are removed during breast cancer surgery. The goal is to see if using it improves surgery outcomes.
Mobile, AlabamaAges 18 years+ - NCT04110756Recruiting
Program to help teens change health behaviors
This study tests a program designed to help teens make healthier choices. It’s for teens who are 15–17 and are currently drinking alcohol, who come to specific UCSF pediatric check-up visits.
San Francisco, CaliforniaAges 15–17 - NCT07089225Recruiting
Using a cannabis journal app to track symptoms in cancer care
This study asks cancer patients who use cannabis to track their symptoms and cannabis use with a smartphone app. The goal is to learn how cannabis affects symptom management during cancer treatment.
Scarborough, MaineAges 18 years+ - NCT07886320RecruitingEarly Phase 1
Adapalene gel for skin irritation from radiation
This trial tests a gel applied to the skin to see if it helps prevent or reduce the painful skin irritation that can happen after radiation therapy. It may be an option for people with breast cancer or head and neck cancer who are about to start radiation.
Kunming, YunnanAges Any age - NCT07884877RecruitingPhase 2
PULSAR radiotherapy plus immunotherapy for advanced liver cancer
This trial combines a special type of radiation therapy (PULSAR) with immunotherapy (drugs that help your immune system fight cancer) for people with advanced liver cancer that cannot be removed by surgery. The goal is to see if this combination can better control the cancer and improve outcomes.
SeoulAges 19 years+
Hear when a new Other Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for other cancer?
- Yes. Clin2 currently lists 12,892 recruiting other cancer studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a other cancer trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a other cancer trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.